UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping

Oct.04.2024
UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping
A UK study shows that there are 5.1 million e-cigarette users among people aged 16 and over, with the usage rate highest among the 16-24 age group at 15.8%. Over 1 million non-regular smokers have started using e-cigarettes, with usage increasing sevenfold over the past three years.

According to a recent report by The Guardian, research data shows that one in every ten people aged 16 and above in the UK is using e-cigarettes. The number of non-regular smokers in the UK who have started using e-cigarettes has increased sevenfold in three years, reaching 1 million. This has raised concerns among health experts.


Before 2021, the usage of e-cigarettes among non-regular adult smokers remained stable, with approximately 1 in 200 people, or about 133,000 individuals, using e-cigarettes. However, a study published in The Lancet Public Health indicates that by 2024, this proportion is projected to increase sharply to 1 in every 28 people, equating to 1.006 million individuals.


Data released this week by the Office for National Statistics in the UK reveals that there are a total of 5.1 million e-cigarette users aged 16 and over in the country. The age group with the highest e-cigarette usage rate is 16 to 24-year-olds, with a rate of 15.8%.


The study also found that the majority of e-cigarette users who had never smoked regularly are using e-cigarettes on a daily basis and for longer periods of time. This sharp increase is mainly driven by young people, with research showing that 14% of non-regular smokers aged 18 to 24 in the UK are now using e-cigarettes.


Researchers warn that the UK government's plans to ban disposable e-cigarettes may not fully address the issue, as some brands have already introduced reusable products. Experts suggest that reducing the appeal of e-cigarette products may require stricter regulations and laws.


Professor Jamie Brown from the Institute of Epidemiology and Health Care at University College London (UCL) believes that although measures to ban disposable e-cigarettes may not be enough to solve the problem, stricter regulations on the appearance, packaging, and marketing of products could be introduced. These measures are unlikely to reduce the effectiveness of e-cigarettes in smoking cessation. He points out that by 2023, the overall prevalence of e-cigarettes seems to be stabilizing, which may provide a reasonable basis for implementing these measures and assessing their effectiveness.


The study analyzed survey data from 153,073 adults in the UK between 2016 and 2024, of which 94,107 had never smoked regularly. The data showed that the proportion of non-smokers who used e-cigarettes increased from 0.5% in 2016-2020 to 3.5% by April 2024, surpassing 1 million people, with over half of them aged between 18 and 24.


Researchers also found that in recent years, the group of people who smoke irregularly tends to be younger, with an increase in the proportion of women. They are more likely to use disposable devices and high-concentration nicotine e-cigarette liquid, and mainly purchase products in supermarkets or convenience stores.


In a statement released by the Department of Health and Social Welfare in the UK, the department emphasized that although e-cigarettes can effectively help adults quit smoking, children and non-smoking adults should not use e-cigarettes. The department stated that the Tobacco and E-cigarette Act will protect future generations from the harms of tobacco and nicotine, save countless lives, and alleviate pressure on the national healthcare system.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Japan Tobacco Inc. (JT) launched Nordic Spirit Rich Melon Medium through selected tobacco retailers in Japan on November 2, 2026, while expanding physical retail distribution for three existing mint products previously sold through the CLUB JT online store. The melon launch brings Nordic Spirit's Japanese portfolio to eight SKUs. All four products are manufactured in Sweden, contain a standard 14 pouches per can and retail for ¥500 including tax. Since introducing Nordic Spirit in Japan in March, JT has expanded the brand's product lineup and distribution through its online store, convenience stores and selected tobacco retailers.
product
Nov.04
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
The Texas Comptroller of Public Accounts ruled in September 2026 that a combustible product made with non-tobacco plant material and 6-methylnicotine (6-MN), a synthetic nicotine analog, qualifies as a taxable tobacco product. The applicant said the product contained neither tobacco leaf nor measurable conventional nicotine. The determination applies reasoning from a May Texas Supreme Court decision involving VELO nicotine pouches, finding that the plant material and 6-MN together perform the functions of tobacco in a conventional smoking product. The ruling carries applicable tax, licensing and reporting obligations but is limited to the facts submitted by the taxpayer. It does not establish a blanket tax classification for all 6-MN products or extend the same conclusion to e-cigarettes.
Regulations
Nov.06
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10